Hisamitsu Pharmaceutical Co., Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3784600003
JPY
4,145.00
-75 (-1.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Feb'25
Feb'24
Feb'23
Feb'22
Feb'21
Feb'20
Feb'19
Net Sales
1,56,006.00
1,41,706.00
1,28,330.00
1,20,193.00
1,14,510.00
1,40,992.00
1,43,408.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,56,006.00
1,41,706.00
1,28,330.00
1,20,193.00
1,14,510.00
1,40,992.00
1,43,408.00
Raw Material Cost
64,810.00
62,735.00
55,630.00
50,126.00
45,337.00
53,388.00
54,727.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
9,763.00
9,486.00
9,826.00
10,164.00
10,540.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.00
18.00
15.00
20.00
10.00
19.00
19.00
Selling and Distribution Expenses
61,397.00
57,189.00
51,314.00
50,117.00
47,735.00
54,371.00
53,369.00
Other Expenses
1,088.00
859.60
0.70
110.70
93.00
32.10
247.30
Total Expenditure (Excl Depreciation)
1,37,110.00
1,28,538.00
1,16,729.00
1,10,856.00
1,03,838.00
1,18,263.00
1,21,128.00
Operating Profit (PBDIT) excl Other Income
18896
13168
11601
9337
10672
22729
22280
Other Income
10,158.00
6,928.00
4,987.00
3,716.00
1,777.00
2,966.00
3,552.00
Operating Profit (PBDIT)
35,389.00
25,268.00
21,540.00
17,374.00
16,528.00
29,946.00
31,574.00
Interest
23.00
18.00
15.00
20.00
10.00
19.00
19.00
Exceptional Items
-343.00
-894.00
-458.00
-77.00
-242.00
482.00
-138.00
Gross Profit (PBDT)
91,196.00
78,971.00
72,700.00
70,067.00
69,173.00
87,604.00
88,681.00
Depreciation
6,335.00
5,172.00
4,952.00
4,321.00
4,079.00
4,251.00
5,742.00
Profit Before Tax
28,687.00
19,186.00
16,113.00
12,956.00
12,197.00
26,155.00
25,673.00
Tax
6,385.00
4,754.00
3,987.00
3,093.00
2,764.00
7,244.00
6,294.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21,758.00
13,970.00
11,743.00
9,658.00
9,251.00
18,694.00
19,204.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
21,758.00
13,970.00
11,743.00
9,658.00
9,251.00
18,694.00
19,204.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
543.00
461.00
383.00
204.00
182.00
217.00
174.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
22,301.00
14,431.00
12,126.00
9,862.00
9,433.00
18,911.00
19,378.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,76,826.00
2,64,877.00
2,56,366.00
2,53,168.00
2,52,299.00
2,49,276.00
2,47,334.00
Earnings per share (EPS)
295.15
181.41
147.87
118.84
113.1
227.3
229.85
Diluted Earnings per share
295.15
181.41
147.87
118.84
113.1
227.3
229.85
Operating Profit Margin (Excl OI)
12.11%
9.29%
9.04%
7.77%
9.32%
16.12%
15.54%
Gross Profit Margin
22.45%
17.19%
16.41%
14.37%
14.21%
21.57%
21.91%
PAT Margin
13.95%
9.86%
9.15%
8.04%
8.08%
13.26%
13.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Feb 2025 is 10.09% vs 10.42% in Feb 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Feb 2025 is 54.54% vs 19.01% in Feb 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Feb 2025 is 37.57% vs 10.80% in Feb 2024

stock-summary

Interest

YoY Growth in year ended Feb 2025 is 27.78% vs 20.00% in Feb 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Feb 2025 has improved from Feb 2024

Compare Annual Results Of Hisamitsu Pharmaceutical Co., Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,56,006.00
3,00,004.00
-1,43,998.00
-48.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,56,006.00
3,00,004.00
-1,43,998.00
-48.00%
Raw Material Cost
64,810.00
1,36,795.00
-71,985.00
-52.62%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
57,319.00
-57,319.00
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
23.00
1,083.00
-1,060.00
-97.88%
Selling and Distribution Expenses
61,397.00
83,511.00
-22,114.00
-26.48%
Other Expenses
1,088.00
-3,493.50
4,581.50
131.14%
Total Expenditure (Excl Depreciation)
1,37,110.00
2,43,773.00
-1,06,663.00
-43.76%
Operating Profit (PBDIT) excl Other Income
18,896.00
56,231.00
-37,335.00
-66.40%
Other Income
10,158.00
3,159.00
6,999.00
221.56%
Operating Profit (PBDIT)
35,389.00
77,338.00
-41,949.00
-54.24%
Interest
23.00
1,083.00
-1,060.00
-97.88%
Exceptional Items
-343.00
-10,140.00
9,797.00
96.62%
Gross Profit (PBDT)
91,196.00
1,63,209.00
-72,013.00
-44.12%
Depreciation
6,335.00
17,948.00
-11,613.00
-64.70%
Profit Before Tax
28,687.00
48,166.00
-19,479.00
-40.44%
Tax
6,385.00
11,628.00
-5,243.00
-45.09%
Provisions and contingencies
0
0
0.00
Profit After Tax
21,758.00
36,247.00
-14,489.00
-39.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
21,758.00
36,247.00
-14,489.00
-39.97%
Share in Profit of Associates
0
0
0.00
Minority Interest
543.00
-403.00
946.00
234.74%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
22,301.00
35,844.00
-13,543.00
-37.78%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,76,826.00
2,86,242.00
-9,416.00
-3.29%
Earnings per share (EPS)
295.15
103.68
191.47
184.67%
Diluted Earnings per share
295.15
103.68
191.47
184.67%
Operating Profit Margin (Excl OI)
12.11%
18.74%
0.00
-6.63%
Gross Profit Margin
22.45%
22.04%
0.00
0.41%
PAT Margin
13.95%
12.08%
0.00
1.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 15,600.60 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 10.09% vs 10.42% in Feb 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 2,230.10 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 54.54% vs 19.01% in Feb 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2,523.10 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 37.57% vs 10.80% in Feb 2024

Annual - Interest
Interest 2.30 Million
in Feb 2025

Figures in Million
stock-summary

YoY Growth in year ended Feb 2025 is 27.78% vs 20.00% in Feb 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.11%
in Feb 2025

Figures in %
stock-summary

YoY Growth in year ended Feb 2025 has improved from Feb 2024